Batch Release & Batch Testing Site Support Services
Ensure pharmaceutical excellence by one batch at a time
Ensure pharmaceutical excellence by one batch at a time
We extend batch release and testing site support services to ensure your products meet high quality and compliance standards. We understand the importance of precise and timely batch release and testing, and are dedicated to supporting your success.
We provide GMP-certified importation, batch testing, and batch release services for human, veterinary, and investigational medicinal products. With multiple QPs and MIA holders, we can perform GMP batch testing and release for sterile, non-sterile, and biological medicinal products. Most of our clients are global manufacturers without mutual recognition agreements (MRA) importing their products within the developed countries. Batch testing is mandatory before batch release, and Zenovel’s integrated solution includes batch release for these manufacturers, allowing them to entrust their products until market release.
Our team of professionals brings extensive experience in pharmaceutical quality control and regulatory affairs.
We advanced testing and release services are powered by state-of-the-art laboratories and advanced technologies.
We work thoroughly with our clients to fully grasp their individual demands and then customise our offerings to fulfil those needs.
Our commitment to strict regulatory standards and integrity ensures the safety and effectiveness of our products in all our operations.
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S Certification) is
Lipinski’s Rule of 5 (Ro5) is a crucial guideline in pharmaceutical development, helping researchers evaluate a compound’s likelihood of becoming an effective oral drug. However, with the rapid evolution of therapeutic strategies, it’s worth considering the relevance of Ro5 in the current drug design landscape. Understanding Lipinski’s Rule of 5
Regulatory affairs (RA) play a crucial role in the pharmaceutical industry; ensuring products meet quality, safety, and efficacy. As the industry grow further the need for qualified professionals to bridge gaps between companies and regulators increases. This blog explores Zenovel regulatory affairs expertise, our various facets, and valuable contribution to
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.